Skip to main content
Signal8

Santhera Pharmaceuticals Holding AG (SPHDF)

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Sector: Biotechnology

Industry: Biotechnology

Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

OTC:SPHDFHealthcare
CLOSED
Mkt Cap-
EV-
Float10.98M
O/S15.31M
VOL110 sh
$ Vol$2K
Inst Own-
SI1.5%
Net Cash/Sh-
EarningsApr 29 · in 5mo
Dilution
Short interest (FINRA)
1.5%
Oct 30 (18d)

Float 10.98M · FMP free float

160.9K
Oct 30 (18d)prev 160.6K▲ 0.2%
999.99
Oct 30 (18d)prev 999.99– 0.0%
Borrow (IBKR)

The cost to borrow SPHDF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 2026160.9K sh
Oct 15, 2026160.6K sh
Sep 30, 2026150.8K sh
Sep 15, 2026138.7K sh
Aug 31, 2026144.9K sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for SPHDF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 160,922 SPHDF shares were sold short (1.47% of a 10.98M-share float, 999.99 days to cover).